IS4772A - Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA. - Google Patents

Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA.

Info

Publication number
IS4772A
IS4772A IS4772A IS4772A IS4772A IS 4772 A IS4772 A IS 4772A IS 4772 A IS4772 A IS 4772A IS 4772 A IS4772 A IS 4772A IS 4772 A IS4772 A IS 4772A
Authority
IS
Iceland
Prior art keywords
asa
oral
modified release
release containing
preparations
Prior art date
Application number
IS4772A
Other languages
English (en)
Other versions
IS1834B (is
Inventor
Klüver Jepsen Svenn
Halskov Søren
Original Assignee
Farmaceutisk Laboratorium Ferring A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4772(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmaceutisk Laboratorium Ferring A/S filed Critical Farmaceutisk Laboratorium Ferring A/S
Publication of IS4772A publication Critical patent/IS4772A/is
Publication of IS1834B publication Critical patent/IS1834B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
IS4772A 1995-12-21 1998-06-15 Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA. IS1834B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (en) 1995-12-21 1996-12-23 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases

Publications (2)

Publication Number Publication Date
IS4772A true IS4772A (is) 1998-06-15
IS1834B IS1834B (is) 2002-11-15

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4772A IS1834B (is) 1995-12-21 1998-06-15 Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA.

Country Status (28)

Country Link
EP (1) EP0871434B2 (is)
JP (1) JP4714836B2 (is)
KR (2) KR100598714B1 (is)
CN (1) CN1155369C (is)
AT (1) ATE205704T1 (is)
AU (1) AU702934B2 (is)
BG (1) BG63484B1 (is)
BR (1) BR9612213A (is)
CA (1) CA2240281C (is)
CZ (1) CZ289290B6 (is)
DE (2) DE871434T1 (is)
DK (1) DK0871434T4 (is)
EE (1) EE03740B1 (is)
ES (1) ES2149733T5 (is)
HK (1) HK1017615A1 (is)
HU (1) HU228856B1 (is)
IL (1) IL124858A (is)
IS (1) IS1834B (is)
NO (1) NO320498B1 (is)
NZ (1) NZ325201A (is)
PL (1) PL186790B1 (is)
PT (1) PT871434E (is)
RU (1) RU2181043C2 (is)
SI (1) SI0871434T2 (is)
SK (1) SK282669B6 (is)
TR (1) TR199801158T2 (is)
UA (1) UA67721C2 (is)
WO (1) WO1997023199A1 (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DK1146862T3 (da) 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
MXPA04003506A (es) * 2001-10-15 2004-07-23 Ferring Bv Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
US8282955B2 (en) * 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
JP5450053B2 (ja) * 2006-04-13 2014-03-26 ニューロテック ファーマシューティカルズ カンパニー リミテッド 細胞損傷及び炎症疾患の治療または予防用薬学組成物
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
AU2009298139B2 (en) 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (en) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
CZ289290B6 (cs) 2001-12-12
SK83498A3 (en) 1999-01-11
BG63484B1 (bg) 2002-03-29
IL124858A (en) 2003-03-12
BG102556A (en) 1999-02-26
PL186790B1 (pl) 2004-02-27
EE03740B1 (et) 2002-06-17
NZ325201A (en) 1998-11-25
UA67721C2 (en) 2004-07-15
HUP0001084A3 (en) 2000-12-28
JP4714836B2 (ja) 2011-06-29
CN1155369C (zh) 2004-06-30
JPH11510191A (ja) 1999-09-07
AU1366197A (en) 1997-07-17
AU702934B2 (en) 1999-03-11
TR199801158T2 (xx) 1998-09-21
DE69615400T3 (de) 2008-08-07
KR19990076584A (ko) 1999-10-15
PL327323A1 (en) 1998-12-07
IL124858A0 (en) 1999-01-26
ES2149733T5 (es) 2008-05-01
NO982904D0 (no) 1998-06-22
HK1017615A1 (en) 1999-11-26
DE871434T1 (de) 2001-04-05
CA2240281A1 (en) 1997-07-03
RU2181043C2 (ru) 2002-04-10
IS1834B (is) 2002-11-15
ATE205704T1 (de) 2001-10-15
CZ194698A3 (cs) 1998-10-14
NO982904L (no) 1998-06-22
ES2149733T1 (es) 2000-11-16
KR100598714B1 (ko) 2006-07-10
BR9612213A (pt) 1999-12-28
DK0871434T4 (da) 2008-04-07
EP0871434B2 (en) 2007-12-12
NO320498B1 (no) 2005-12-12
EE9800191A (et) 1998-12-15
EP0871434B1 (en) 2001-09-19
SI0871434T2 (sl) 2008-04-30
PT871434E (pt) 2002-02-28
ES2149733T3 (es) 2002-04-01
SK282669B6 (sk) 2002-11-06
KR100542544B1 (ko) 2006-05-10
DK0871434T3 (da) 2002-01-07
CA2240281C (en) 2007-02-27
DE69615400D1 (de) 2001-10-25
HUP0001084A2 (hu) 2000-11-28
EP0871434A1 (en) 1998-10-21
DE69615400T2 (de) 2002-05-23
KR20050087886A (ko) 2005-08-31
HU228856B1 (en) 2013-06-28
CN1207672A (zh) 1999-02-10
SI0871434T1 (en) 2002-04-30
WO1997023199A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
IS4772A (is) Lyfjablöndur til inntöku um munn með breytta losun sem innihalda 5-ASA.
DK0825858T3 (da) Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
GEP20053455B (en) Pharmaceutical Preparations
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
DE69634080D1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel